Brandon May

Using the inter-eye percentage difference may help surpass limitations associated with device and proprietary segmentation algorithms.

It is recommended that physicians educate their patients/their patients’ family members regarding the steps to take in case of a potential overdose.

The clinical spectrum and optimal treatment approach for PD-1-related neurological complications is not clear.

Previous research has suggested an association between androgen deprivation therapy and risk for Alzheimer dementia.

Painful signs and symptoms frequently occur prior to cluster headache attacks.

Previous research suggests a possible role for sodium intake in the pathogenesis of multiple sclerosis.

A better understanding of characteristics of cerebral lesions may help expedite treatment and improve functional outcomes.

Monthly injections of 120 mg or 240 mg galcanezumab helped reduce number of migraine days.

Newer antiepileptic drugs were associated with fewer adverse effects in patients with ischemic stroke.

Researchers assessed annualized relapse rate, confirmed disability worsening, confirmed disability improvement, brain volume loss, and adverse events.

The investigators noted that rivaroxaban was associated with significantly reduced length of hospital stay compared with warfarin.

For pediatric patients with TBI, there is no apparent benefit of ICP monitoring for improving functional survival.

Older adults with sleep-disordered breathing have a 26% greater risk for developing cognitive impairment and a small risk for deteriorating executive function.

The APOE ε2/ε3 genotype was associated with a protective effect in women and decreased their AD risk to a greater degree than men.

The findings align with current guidelines to administer IV tPA regardless of whether or not a patient with ischemic stroke is set to undergo mechanical thrombectomy.

Rates of neurologic complications increased in the months after the Zika virus outbreak in Brazil.

Previous reports have suggested that statins or the low levels of LDL cholesterol they promote may have an adverse impact on cognition.

Findings from this trial challenge current recommended systolic blood pressure targets for older adults.

Patients with postural instability and gait disturbances had worse sleep scores than those with tremor-dominant Parkinson’s.

There is some evidence that suggests intravenous thrombolysis for stroke may impair the blood-brain barrier and cause cerebral edema.

Surprisingly, no evidence was found to suggest that patients with these markers benefit from intensive blood pressure reduction.

Enrollment of patients with only early Parkinson’s disease in this trial prevents generalization of the study’s findings across the entire Parkinson’s population.

The findings may be less applicable to low-volume stroke centers who have less experience in this
treatment.

Further research in a larger cohort may be required to detect any changes in treatment effect in this patient group.

Patients with both Parkinson’s and rapid eye movement sleep behavior disorder were much more likely to experience mild cognitive impairment.

Patients taking levodopa therapy may experience neuropsychiatric fluctuations characterized by changes in mood, motivation, and anxiety while in ON and OFF states of drug therapy.

Opioid therapy was shown to improve quality of life in patients with comorbid fibromyalgia and PTSD.

Women and patients of African-American race face an increased risk of experiencing poststroke recrudescence.